Synapse

← Jerry R. McGhee

Papers by Jerry R. McGhee

Page 2 · newest first

  1. Vaccines for Mucosal Immunity to Combat Emerging Infectious DiseasesEmerging infectious diseases · 2000
  2. Syntaxin 1A is expressed in airway epithelial cells, where it modulates CFTR Cl– currentsJournal of Clinical Investigation · 2000
  3. Mucosally Induced Immunoglobulin E-Associated Inflammation in the Respiratory TractInfection and Immunity · 2000
  4. γδ T cells regulate mucosally induced tolerance in a dose-dependent fashionInternational Immunology · 1999
  5. Expression of Recombinant EnterotoxigenicEscherichia coliColonization Factor Antigen I bySalmonella typhimuriumElicits a Biphasic T Helper Cell ResponseInfection and Immunity · 1999
  6. Human Interleukin‐12 Enhances Interferon‐γ–Producing Influenza‐Specific Memory CD8+Cytotoxic T LymphocytesThe Journal of Infectious Diseases · 1999
  7. Lipopolysaccharide- and Cholera Toxin-Specific Subclass Distribution of B-Cell Responses in CholeraClinical and Diagnostic Laboratory Immunology · 1999
  8. Partial IgA-Deficiency with Increased Th2-Type Cytokines in TGF-β1 Knockout MiceThe Journal of Immunology · 1999
  9. Mucosal immunity and tolerance: relevance to vaccine developmentImmunological Reviews · 1999
  10. Direct Effects on Antigen-Presenting Cells and T Lymphocytes Explain the Adjuvanticity of a Nontoxic Cholera Toxin MutantThe Journal of Immunology · 1999
  11. Hapten-induced Colitis Is Associated with Colonic Patch Hypertrophy and T Helper Cell 2–Type ResponsesThe Journal of Experimental Medicine · 1999
  12. Strategies for mucosal vaccine development.American Journal of Tropical Medicine and Hygiene · 1999
  13. Lymphotactin Acts as an Innate Mucosal AdjuvantThe Journal of Immunology · 1999
  14. Mechanisms for induction of acquired host immunity by neutrophil peptide defensinsProceedings of the National Academy of Sciences · 1999
  15. IL-12 Is an Effective Adjuvant for Induction of Mucosal ImmunityThe Journal of Immunology · 1999
  16. Use of Intranasal IL-12 to Target Predominantly Th1 Responses to Nasal and Th2 Responses to Oral Vaccines Given with Cholera ToxinThe Journal of Immunology · 1999
  17. Nasal Immunization of Nonhuman Primates with Simian Immunodeficiency Virus p55gag and Cholera Toxin Adjuvant Induces Th1/Th2 Help for Virus-Specific Immune Responses in Reproductive TissuesThe Journal of Immunology · 1998
  18. A Nontoxic Adjuvant for Mucosal Immunity to Pneumococcal Surface Protein AThe Journal of Immunology · 1998
  19. Novel approaches for the induction of T helper 1 (Th1)- or Th2-type mucosal and parenteral immune responsesExpert Opinion on Investigational Drugs · 1998
  20. Testosterone and IL-6 Requirements for Human C-Reactive Protein Gene Expression in Transgenic MiceThe Journal of Immunology · 1998
  21. Influenza Virus-Infected Epithelial Cells Present Viral Antigens to Antigen-Specific CD8+Cytotoxic T LymphocytesJournal of Virology · 1998
  22. A Mucosal Intranet: Intestinal Epithelial Cells Down-Regulate Intraepithelial, But Not Peripheral, T LymphocytesThe Journal of Immunology · 1998
  23. Dendritic Cells from Peyer's Patch and Spleen Induce Different T Helper Cell ResponsesJournal of Interferon & Cytokine Research · 1998
  24. Lack of Orally Induced Systemic Unresponsiveness in IFN-γ Knockout MiceThe Journal of Immunology · 1998
  25. Induction of Th2 Cytokine Expression for p27‐Specific IgA B Cell Responses after Targeted Lymph Node Immunization with Simian Immunodeficiency Virus Antigens in Rhesus MacaquesThe Journal of Infectious Diseases · 1998
  26. Targeted lymph-node immunization with whole inactivated simian immunodeficiency virus (SIV) or envelope and core subunit antigen vaccines does not reliably protect rhesus macaques from vaginal challenge with SIVmac251AIDS · 1998
  27. Arginine Enhances Induction of T Helper 1 and T Helper 2 Cytokine Synthesis by Peyer’s Patch αβ T Cells and Antigen-Specific Mucosal Immune ResponseBioscience Biotechnology and Biochemistry · 1998
  28. Spontaneously hypertensive rat: cholera toxin converts suppression to immunity through a Th2 cell-IL-4 pathwayAJP Regulatory Integrative and Comparative Physiology · 1997
  29. Oral immunization with simian immunodeficiency virus p55gag and cholera toxin elicits both mucosal IgA and systemic IgG immune responses in nonhuman primatesThe Journal of Immunology · 1997
  30. A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunityProceedings of the National Academy of Sciences · 1997
  31. Mutants in the ADP-ribosyltransferase Cleft of Cholera Toxin Lack Diarrheagenicity but Retain AdjuvanticityThe Journal of Experimental Medicine · 1997
  32. Oral but Not Parenteral Interleukin (IL)-12 Redirects T Helper 2 (Th2)-type Responses to an Oral Vaccine Without Altering Mucosal IgA ResponsesThe Journal of Experimental Medicine · 1997
  33. Oral immunization with PspA elicits protective humoral immunity against Streptococcus pneumoniae infectionInfection and Immunity · 1997
  34. Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, fas, and gamma interferonJournal of Virology · 1997
  35. Molecular and cellular mechanisms for periodontal diseases: role of Th1 and Th2 type cytokines in induction of mucosal inflammationJournal of Periodontal Research · 1997
  36. Interleukin‐12 Alters Helper T‐Cell Subsets and Antibody Profiles Induced by the Mucosal Adjuvant Cholera ToxinAnnals of the New York Academy of Sciences · 1996
  37. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by toleranceThe Journal of Immunology · 1996
  38. Oral immunization of interleukin-4 (IL-4) knockout mice with a recombinant Salmonella strain or cholera toxin reveals that CD4+ Th2 cells producing IL-6 and IL-10 are associated with mucosal immunoglobulin A responsesInfection and Immunity · 1996
  39. gamma/delta T cell-deficient mice have impaired mucosal immunoglobulin A responses.The Journal of Experimental Medicine · 1996
  40. Epitope maps of the Escherichia coli heat-labile toxin B subunit for development of a synthetic oral vaccineInfection and Immunity · 1996
  41. Dendritic cells from different tissues induce production of different T cell cytokine profilesJournal of Leukocyte Biology · 1996
  42. Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile EnterotoxinThe Journal of Infectious Diseases · 1996
  43. Selected Th1 and Th2 cytokine mRNA expression by CD4+ T cells isolated from inflamed human gingival tissuesClinical & Experimental Immunology · 1996
  44. Regulation of mucosal and systemic antibody responses by T helper cell subsets, macrophages, and derived cytokines following oral immunization with live recombinant SalmonellaThe Journal of Immunology · 1996
  45. Role of γδ T Cells in the Regulation of Mucosal IgA Response and Oral ToleranceaAnnals of the New York Academy of Sciences · 1996
  46. The Role of Th1 and Th2 Cells for Mucosal IgA ResponsesaAnnals of the New York Academy of Sciences · 1996
  47. Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4The Journal of Immunology · 1995
  48. Polarized Th2 cytokine expression by both mucosal γδ and αβ T cellsEuropean Journal of Immunology · 1995
  49. Intratracheal Gene Delivery with Adenoviral Vector Induces Elevated Systemic IgG and Mucosal IgA Antibodies to Adenovirus and β -GalactosidaseHuman Gene Therapy · 1995
  50. A mutant pertussis toxin molecule that lacks ADP-ribosyltransferase activity, PT-9K/129G, is an effective mucosal adjuvant for intranasally delivered proteinsENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) · 1995